Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor

L. Martarello, C. Kilts, T. Ely, M. Owens, Charles Nemeroff, M. Camp, M. M. Goodman

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Fluorine-18 labeled fluorobutyl[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo [2,3-d] pyrimidin-4-yl]ethylamine (FBPPA) and iodine-123 labeled butyl[2,5-dimethyl-7-(4-iodo-2,6-dimethylphenyl)-7H-pyrrolo[2,3-d] pyrimidin-4-yl]ethyl-amine (IBPPA) were synthesized in the development of a CRF receptor ligand. The methods of synthesis, in vitro binding assays, radiolabeling and in vivo tissue distribution in rats are described. Fluorine-18 labeled FBPPA was prepared with high specific activity (3 × 104 Ci/mmol) by nucleophilic displacement with an average radiochemical yield of 6% (EOB). Iodine-123 labeled IBPPA was prepared by electrophilic iododestannylation with good yield (60%) and high specific activity (3.3 × 103 Ci/mmol). The retention of FBPPA and IBPPA in the pituitary was good (1.16% i.d./g and 2.35% i.d./g respectively at 60 min). However, the accumulation of radioactivity in the brain for both radiotracers was very low at all time points of the study, which demonstrated the difficulties for these radiopharmaceuticals to penetrate the blood brain barrier (BBB).

Original languageEnglish
Pages (from-to)187-195
Number of pages9
JournalNuclear Medicine and Biology
Volume28
Issue number2
DOIs
StatePublished - Apr 18 2001
Externally publishedYes

Fingerprint

Fluorine
Single-Photon Emission-Computed Tomography
Iodine
Ligands
Corticotropin-Releasing Hormone Receptors
Radiopharmaceuticals
Tissue Distribution
Blood-Brain Barrier
Radioactivity
Amines
Brain
CRF receptor type 1
pyrrolopyrimidine
In Vitro Techniques
fluorobutyl(2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)ethylamine

Keywords

  • CRF receptor
  • Fluorine-18
  • Iodine-123
  • Radiolabeling

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor. / Martarello, L.; Kilts, C.; Ely, T.; Owens, M.; Nemeroff, Charles; Camp, M.; Goodman, M. M.

In: Nuclear Medicine and Biology, Vol. 28, No. 2, 18.04.2001, p. 187-195.

Research output: Contribution to journalArticle

Martarello, L. ; Kilts, C. ; Ely, T. ; Owens, M. ; Nemeroff, Charles ; Camp, M. ; Goodman, M. M. / Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor. In: Nuclear Medicine and Biology. 2001 ; Vol. 28, No. 2. pp. 187-195.
@article{e36fff94d29649429d0df40e7ab3f593,
title = "Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor",
abstract = "Fluorine-18 labeled fluorobutyl[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo [2,3-d] pyrimidin-4-yl]ethylamine (FBPPA) and iodine-123 labeled butyl[2,5-dimethyl-7-(4-iodo-2,6-dimethylphenyl)-7H-pyrrolo[2,3-d] pyrimidin-4-yl]ethyl-amine (IBPPA) were synthesized in the development of a CRF receptor ligand. The methods of synthesis, in vitro binding assays, radiolabeling and in vivo tissue distribution in rats are described. Fluorine-18 labeled FBPPA was prepared with high specific activity (3 × 104 Ci/mmol) by nucleophilic displacement with an average radiochemical yield of 6{\%} (EOB). Iodine-123 labeled IBPPA was prepared by electrophilic iododestannylation with good yield (60{\%}) and high specific activity (3.3 × 103 Ci/mmol). The retention of FBPPA and IBPPA in the pituitary was good (1.16{\%} i.d./g and 2.35{\%} i.d./g respectively at 60 min). However, the accumulation of radioactivity in the brain for both radiotracers was very low at all time points of the study, which demonstrated the difficulties for these radiopharmaceuticals to penetrate the blood brain barrier (BBB).",
keywords = "CRF receptor, Fluorine-18, Iodine-123, Radiolabeling",
author = "L. Martarello and C. Kilts and T. Ely and M. Owens and Charles Nemeroff and M. Camp and Goodman, {M. M.}",
year = "2001",
month = "4",
day = "18",
doi = "10.1016/S0969-8051(00)00199-2",
language = "English",
volume = "28",
pages = "187--195",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor

AU - Martarello, L.

AU - Kilts, C.

AU - Ely, T.

AU - Owens, M.

AU - Nemeroff, Charles

AU - Camp, M.

AU - Goodman, M. M.

PY - 2001/4/18

Y1 - 2001/4/18

N2 - Fluorine-18 labeled fluorobutyl[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo [2,3-d] pyrimidin-4-yl]ethylamine (FBPPA) and iodine-123 labeled butyl[2,5-dimethyl-7-(4-iodo-2,6-dimethylphenyl)-7H-pyrrolo[2,3-d] pyrimidin-4-yl]ethyl-amine (IBPPA) were synthesized in the development of a CRF receptor ligand. The methods of synthesis, in vitro binding assays, radiolabeling and in vivo tissue distribution in rats are described. Fluorine-18 labeled FBPPA was prepared with high specific activity (3 × 104 Ci/mmol) by nucleophilic displacement with an average radiochemical yield of 6% (EOB). Iodine-123 labeled IBPPA was prepared by electrophilic iododestannylation with good yield (60%) and high specific activity (3.3 × 103 Ci/mmol). The retention of FBPPA and IBPPA in the pituitary was good (1.16% i.d./g and 2.35% i.d./g respectively at 60 min). However, the accumulation of radioactivity in the brain for both radiotracers was very low at all time points of the study, which demonstrated the difficulties for these radiopharmaceuticals to penetrate the blood brain barrier (BBB).

AB - Fluorine-18 labeled fluorobutyl[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo [2,3-d] pyrimidin-4-yl]ethylamine (FBPPA) and iodine-123 labeled butyl[2,5-dimethyl-7-(4-iodo-2,6-dimethylphenyl)-7H-pyrrolo[2,3-d] pyrimidin-4-yl]ethyl-amine (IBPPA) were synthesized in the development of a CRF receptor ligand. The methods of synthesis, in vitro binding assays, radiolabeling and in vivo tissue distribution in rats are described. Fluorine-18 labeled FBPPA was prepared with high specific activity (3 × 104 Ci/mmol) by nucleophilic displacement with an average radiochemical yield of 6% (EOB). Iodine-123 labeled IBPPA was prepared by electrophilic iododestannylation with good yield (60%) and high specific activity (3.3 × 103 Ci/mmol). The retention of FBPPA and IBPPA in the pituitary was good (1.16% i.d./g and 2.35% i.d./g respectively at 60 min). However, the accumulation of radioactivity in the brain for both radiotracers was very low at all time points of the study, which demonstrated the difficulties for these radiopharmaceuticals to penetrate the blood brain barrier (BBB).

KW - CRF receptor

KW - Fluorine-18

KW - Iodine-123

KW - Radiolabeling

UR - http://www.scopus.com/inward/record.url?scp=0035057666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035057666&partnerID=8YFLogxK

U2 - 10.1016/S0969-8051(00)00199-2

DO - 10.1016/S0969-8051(00)00199-2

M3 - Article

C2 - 11295429

AN - SCOPUS:0035057666

VL - 28

SP - 187

EP - 195

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 2

ER -